CFG
BIO icon

Cooper Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cooper Financial Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-457
Closed -$219K – 317
2023
Q1 		$219K Buy
+457
New +$214K 0.06% 275
2022
Q1 		– Sell
-811
Closed -$613K – 249
2021
Q4 		$613K Buy
811
+10
+1% +$7.48K 0.23% 101
2021
Q3 		$598K Buy
801
+59
+8% +$44.2K 0.12% 115
2021
Q2 		$478K Buy
742
+41
+6% +$25K 0.1% 126
2021
Q1 		$400K Sell
701
-14
-2% -$8.29K 0.09% 146
2020
Q4 		$417K Sell
715
-19
-3% -$10.8K 0.09% 173
2020
Q3 		$378K Sell
734
-54
-7% -$27.4K 0.11% 130
2020
Q2 		$356K Buy
+788
New +$348K 0.12% 125

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return